ViewRay Announces Conference Call for Fourth Quarter and Full Year 2021 Financial Results to be Held After Market on February 24, 2022

Rhea-AI Summary

ViewRay, Inc. (Nasdaq: VRAY) has announced a conference call scheduled for February 24, 2022, at 4:30 p.m. ET to discuss its fourth quarter and full year 2021 financial results. Domestic callers can dial (844) 277-1426, while international callers should use (336) 525-7129. A live webcast will also be available on the company's investor relations page. ViewRay specializes in the MRIdian® MR-Guided Radiation Therapy System, designed for advanced radiation oncology applications, addressing challenges such as beam distortion and skin toxicity.

CLEVELAND, Feb. 10, 2022 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its fourth quarter and full year 2021 financial results.

ViewRay will hold a conference call to discuss results on Thursday, February 24, 2022 at 4:30 p.m. ET. The dial-in numbers are (844) 277-1426 for domestic callers and (336) 525-7129 for international callers. The confirmation number is 9988699. A live webcast of the conference call will be available on the investor relations page of ViewRay's corporate website at http://investors.viewray.com/events-and-presentations/upcoming-events.

After the live webcast, a replay will remain available online on the investor relations page of ViewRay's website, under "Financial Events and Webinars", for 14 days following the call. In addition, a telephonic replay of the call will be available until March 3, 2022. The replay dial-in numbers are (855) 859-2056 for domestic callers and (404) 537-3406 for international callers. Please use the conference ID number 9988699.

About ViewRay®
ViewRay, Inc. (Nasdaq: VRAY), designs, manufactures, and markets the MRIdian® MR-Guided Radiation Therapy System. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purpose-built to address specific challenges, including beam distortion, skin toxicity, and other concerns that potentially may arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.

 

View original content:https://www.prnewswire.com/news-releases/viewray-announces-conference-call-for-fourth-quarter-and-full-year-2021-financial-results-to-be-held-after-market-on-february-24-2022-301479500.html

SOURCE ViewRay, Inc.

FAQ

When is ViewRay's fourth quarter 2021 earnings call?

ViewRay's fourth quarter 2021 earnings call is scheduled for February 24, 2022, at 4:30 p.m. ET.

How can I access the live webcast of ViewRay's earnings call?

The live webcast of ViewRay's earnings call can be accessed through their investor relations page on their corporate website.

What is the purpose of the February 24, 2022, conference call held by ViewRay?

The conference call is held to discuss the fourth quarter and full year 2021 financial results of ViewRay.

What is MRIdian, and how does it relate to ViewRay?

MRIdian is the MR-Guided Radiation Therapy System designed and manufactured by ViewRay, focused on advanced radiation oncology.